Daniel Abdun Nabi is of Aptevo Therapeutics Inc.. Currently has a direct ownership of 277 shares of APVO, which is worth approximately $1,332. The most recent transaction as insider was on Jun 02, 2024, when has been sold 81 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 277
0% 3M change
96.68% 12M change
Total Value Held $1,332

Daniel Abdun-Nabi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2024
BUY
Exercise of conversion of derivative security
-
81 Added 22.63%
277 Common Stock
Jun 01 2024
BUY
Exercise of conversion of derivative security
-
7 Added 3.45%
196 Common Stock
Aug 09 2023
BUY
Exercise of conversion of derivative security
-
3,571 Added 29.98%
8,339 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
-
297 Added 5.86%
4,768 Common Stock
Jun 01 2022
BUY
Exercise of conversion of derivative security
-
298 Added 3.55%
8,108 Common Stock

Also insider at

RGNX
REGENXBIO Inc. Healthcare
DA

Daniel Abdun Nabi

Seattle, WA

Track Institutional and Insider Activities on APVO

Follow Aptevo Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APVO shares.

Notify only if

Insider Trading

Get notified when an Aptevo Therapeutics Inc. insider buys or sells APVO shares.

Notify only if

News

Receive news related to Aptevo Therapeutics Inc.

Track Activities on APVO